Ogorek Anthony Joseph’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $472K | Sell |
1,878
-4
| -0.2% | -$861 | 0.12% | 56 |
|
|
2026
Q1 | $409K | Sell |
1,882
-4
| -0.2% | -$887 | 0.11% | 55 |
|
|
2025
Q4 | $430K | Sell |
1,886
-53
| -3% | -$12.1K | 0.12% | 55 |
|
|
2025
Q3 | $448K | Buy |
1,939
+344
| +22% | +$70.1K | 0.13% | 52 |
|
|
2025
Q2 | $296K | Buy |
1,595
+21
| +1% | +$3.9K | 0.09% | 57 |
|
|
2025
Q1 | $329K | Buy |
1,574
+351
| +29% | +$68.2K | 0.11% | 56 |
|
|
2024
Q4 | $217K | Hold |
1,223
| – | – | 0.07% | 63 |
|
|
2024
Q3 | $241K | Buy |
1,223
+62
| +5% | +$11.6K | 0.08% | 55 |
|
|
2024
Q2 | $199K | Hold |
1,161
| – | – | 0.07% | 59 |
|
|
2024
Q1 | $211K | Sell |
1,161
-115
| -9% | -$19.8K | 0.07% | 57 |
|
|
2023
Q4 | $197K | Buy |
1,276
+100
| +9% | +$14.6K | 0.07% | 59 |
|
|
2023
Q3 | $175K | Buy |
1,176
+15
| +1% | +$2.2K | 0.07% | 74 |
|
|
2023
Q2 | $156K | Hold |
1,161
| – | – | 0.06% | 72 |
|
|
2023
Q1 | $185K | Hold |
1,161
| – | – | 0.08% | 69 |
|
|
2022
Q4 | $187K | Hold |
1,161
| – | – | 0.08% | 59 |
|
|
2022
Q3 | $155K | Hold |
1,161
| – | – | 0.07% | 56 |
|
|
2022
Q2 | $177K | Hold |
1,161
| – | – | 0.08% | 56 |
|
|
2022
Q1 | $188K | Hold |
1,161
| – | – | 0.08% | 55 |
|
|
2021
Q4 | $157K | Hold |
1,161
| – | – | 0.07% | 57 |
|
|
2021
Q3 | $125K | Hold |
1,161
| – | – | 0.06% | 59 |
|
|
2021
Q2 | $130K | Hold |
1,161
| – | – | 0.06% | 60 |
|
|
2021
Q1 | $125K | Hold |
1,161
| – | – | 0.06% | 55 |
|
|
2020
Q4 | $124K | Hold |
1,161
| – | – | 0.07% | 41 |
|
|
2020
Q3 | $101K | Hold |
1,161
| – | – | 0.06% | 43 |
|
|
2020
Q2 | $113K | Hold |
1,161
| – | – | 0.08% | 32 |
|
|
2020
Q1 | $88K | Hold |
1,161
| – | – | 0.05% | 33 |
|
|
2019
Q4 | $102K | Hold |
1,161
| – | – | 0.05% | 35 |
|
|
2019
Q3 | $87K | Hold |
1,161
| – | – | 0.05% | 31 |
|
|
2019
Q2 | $84K | Hold |
1,161
| – | – | 0.06% | 32 |
|
|
2019
Q1 | $93K | Hold |
1,161
| – | – | 0.06% | 29 |
|
|
2018
Q4 | $107K | Hold |
1,161
| – | – | 0.09% | 26 |
|
|
2018
Q3 | $109K | Hold |
1,161
| – | – | 0.08% | 27 |
|
|
2018
Q2 | $107K | Hold |
1,161
| – | – | 0.08% | 28 |
|
|
2018
Q1 | $109K | Hold |
1,161
| – | – | 0.09% | 26 |
|
|
2017
Q4 | $112K | Hold |
1,161
| – | – | 0.09% | 20 |
|
|
2017
Q3 | $103K | Hold |
1,161
| – | – | 0.1% | 19 |
|
|
2017
Q2 | $84K | Hold |
1,161
| – | – | 0.08% | 22 |
|
|
2017
Q1 | $75K | Hold |
1,161
| – | – | 0.08% | 21 |
|
|
2016
Q4 | $73K | Hold |
1,161
| – | – | 0.06% | 26 |
|
|
2016
Q3 | $73K | Hold |
1,161
| – | – | 0.06% | 26 |
|
|
2016
Q2 | $71K | Hold |
1,161
| – | – | 0.06% | 25 |
|
|
2016
Q1 | $66K | Hold |
1,161
| – | – | 0.05% | 26 |
|
|
2015
Q4 | $69K | Hold |
1,161
| – | – | 0.06% | 31 |
|
|
2015
Q3 | $63K | Hold |
1,161
| – | – | 0.05% | 27 |
|
|
2015
Q2 | $78K | Hold |
1,161
| – | – | 0.06% | 26 |
|
|
2015
Q1 | $68K | Hold |
1,161
| – | – | 0.05% | 26 |
|
|
2014
Q4 | $76K | Buy |
+1,161
| New | +$73.2K | 0.06% | 25 |
|
Other funds holding ABBV
Ogorek Anthony Joseph's ABBV Position: Q2 2026 in Review
Ogorek Anthony Joseph reduced its AbbVie (ABBV) stake by 0.21% in Q2 2026, selling an estimated $861 and leaving 1,878 shares worth $472K. The position accounts for 0.12% of the portfolio, ranked #56.
Ogorek Anthony Joseph first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Ogorek Anthony Joseph held 1,878 shares of AbbVie worth $472K as of Q2 2026.
- Ogorek Anthony Joseph sold 4 AbbVie shares in Q2 2026, an estimated $861.
- AbbVie made up 0.12% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #56 holding.
- Ogorek Anthony Joseph first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.